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Background
The natural history of vertically acquired HCV infection is
unclear, with few studies regarding children prospectively
followed from birth at a single centre and mostly with a
short follow-up. This limited information casts doubts on
the use, in childhood, of antiviral drugs commonly
employed in adults with chronic HCV infection.
Materials and methods
All children with vertically acquired HCV infection who
came to our attention and were regularly followed from
the first months of life were included in this analysis. One
child with double HCV and HIV infection was excluded.
HCV associated clinical manifestations, viral genotype,
persistence of viremia and HCV antibodies, liver bio-
chemistry (ALT levels, bilirubin, alpha fetoprotein, coagu-
lation parameters), liver ultrasound and other
investigations to identify extrahepatic manifestations (e.g.
the appearance of auto-antibodies or cryoglobulins, C3
and C4 concentrations) were evaluated.
Results
Twenty-five children were studied; their median age at the
last check was 8.7 years (range 2.0-17.4 years). One child
developed hepatomegaly, all the others were asympto-
matic. Genotypes 1 and 3 were those most commonly
found. Serum HCV-RNA was persistently detected in 68%
(17/25) of patients, while viremia was no longer detected
in 8 (32%) children in the last several determinations.
Anti-HCV antibodies persisted over time in all but one
child, who had two positive PCRs in the first months of
life and then seroreverted. Most children had increased
ALT levels in the first three years of life (median of 64.0
mU/IL, range 11-678 mUI/L). Subsequently ALT levels
normalised in 12 children (median 22,75 mU/IL, range
15.6-39.5) and remained enhanced in 10 (median 64,2
mU/IL, range 47.8-92.7). The liver ultrasound was con-
stantly normal in all but two cases, who showed signs of
steatosis. Seventeen patients (68%) developed auto-anti-
bodies: 14 anti-smooth muscle (SMA), 1 anti-nuclear
antibody (ANA), 1 anti-liver-kidney microsomal Type 1
(LKM1) antibody, and 1 ANA + LKM1. Cryoglobulins
were transiently detected in 7 children (28%), including
one who had mixed type II cryoglobulinemia, though
with no concomitant clinical manifestations. C3 and C4
levels were always normal.
Conclusions
Our findings confirm that vertically acquired HCV infec-
tion is usually asymtpomatic in childhood and ALT levels
remain within the normal range in a large proportion of
cases after the first period of life. However, viremia per-
sists in at least two thirds of children and, of these, a sig-
nificant percentage develops autoantibodies and/or
cryoglobulins.
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